Prostatype Genomics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
06 Sep 24 | Sell€3,605 | Anders Lundberg | Individual | 1,749,849 | €0.0021 |
Insider Trading Volume
Insider Buying: PGO insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 1,932,680 | 0.195% |
Institutions | 3,099,406 | 0.313% |
Individual Insiders | 9,409,503 | 0.95% |
General Public | 976,369,597 | 98.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 729.4%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
8,461,519 | €9.7k | 1,100% | no data | |||
3,079,911 | €3.5k | 0% | no data | |||
1,932,680 | €2.2k | -47.5% | no data | |||
632,579 | €727.8 | 4,170% | no data | |||
175,128 | €201.5 | -29.4% | no data | |||
100,000 | €115.0 | 0% | no data | |||
19,495 | €22.5 | 0% | no data | |||
18,848 | €21.7 | 0% | no data | |||
11,478 | €13.2 | 0% | no data | |||
9,951 | €11.4 | 0% | no data |